Bone and Cancer
Bone and Cancer
Bone and CancerBone and Cancer Foundation, PO Box 287452 Bone and Cancer New York, NY 10128-0025  
Toll Free: 888 862-0999 Bone and Cancer Email: bcfdn@aol.com  
Bone and Cancer

Clinical Trials

Claritin Syrup (loratadine)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved October 1996

Specific Treatments:

seasonal allergies in children

General Information

Claritin Syrup has been approved as a non-drowsy antihistamine syrup for children as young as six years of age. In addition, the indication for Claritin tablets was expanded to include children age six years and up.

Available only by prescription in a once-daily formula, Claritin Syrup is indicated for the treatment of allergy symptoms, including itchy, watery eyes; runny nose; itchy palate; sneezing; and idiopathic chronic urticaria (hives).

Claritin Syrup, in an alcohol-free and dye-free fruit flavored formula, is administered orally at a dose of two teaspoons once-per-day for children as young as six years of age.

Clinical Results

In controlled clinical trials using the recommended dose, the incidence of the most commonly reported adverse events was comparable to placebo.

 How To Order Publications:
  Glossary
  FAQ

Information About

Clinical Trials



 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 


  Copyright 2011 - The Bone and Cancer Foundation